Total Payments
$6,791
2024 Payments
$1,182
Companies
25
Transactions
372
Medicare Patients
17,152
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$6,119 (90.1%)
Education$672.43 (9.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,119 | 363 | 90.1% |
| Education | $672.43 | 9 | 9.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,574 | 111 | $0 (2024) |
| Janssen Biotech, Inc. | $1,479 | 63 | $0 (2024) |
| GENZYME CORPORATION | $606.17 | 28 | $0 (2024) |
| Lilly USA, LLC | $543.93 | 32 | $0 (2024) |
| PFIZER INC. | $517.51 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $425.31 | 23 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $344.51 | 14 | $0 (2023) |
| Incyte Corporation | $265.99 | 17 | $0 (2024) |
| LEO Pharma Inc. | $241.77 | 17 | $0 (2023) |
| Sun Pharmaceutical Industries Inc. | $116.96 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,182 | 57 | Janssen Biotech, Inc. ($310.76) |
| 2023 | $1,604 | 85 | ABBVIE INC. ($322.60) |
| 2022 | $1,053 | 71 | ABBVIE INC. ($411.54) |
| 2021 | $783.73 | 44 | Janssen Biotech, Inc. ($277.76) |
| 2020 | $554.98 | 29 | Janssen Biotech, Inc. ($225.90) |
| 2019 | $686.95 | 33 | Janssen Biotech, Inc. ($159.82) |
| 2018 | $530.58 | 31 | AbbVie, Inc. ($155.81) |
| 2017 | $395.78 | 22 | Janssen Biotech, Inc. ($109.33) |
All Payment Transactions
372 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Immunology | ||||||
| 10/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $27.69 | General |
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 09/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Immunology | ||||||
| 09/06/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 08/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.17 | General |
| Category: Dermatology | ||||||
| 08/15/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: DERMATOLOGY | ||||||
| 08/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $34.28 | General |
| Category: Immunology | ||||||
| 08/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Immunology | ||||||
| 08/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 5,120 | 8,874 | $1.8M | $556,428 |
| 2022 | 32 | 4,313 | 7,439 | $1.5M | $478,224 |
| 2021 | 29 | 4,018 | 6,432 | $1.3M | $439,156 |
| 2020 | 30 | 3,701 | 6,333 | $1.3M | $384,537 |
Total Patients
17,152
Total Services
29,078
Medicare Billing
$1.9M
Procedure Codes
125
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 276 | 348 | $469,800 | $155,056 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 980 | 1,353 | $194,117 | $76,428 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 578 | 792 | $155,105 | $65,483 | 42.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 551 | 657 | $131,400 | $39,122 | 29.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 386 | 470 | $98,700 | $34,859 | 35.3% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 76 | 96 | $81,600 | $28,683 | 35.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 639 | 862 | $122,312 | $28,292 | 23.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 111 | 114 | $65,550 | $21,928 | 33.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 474 | 2,699 | $134,950 | $11,880 | 8.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 80 | 89 | $38,804 | $7,995 | 20.6% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 69 | 69 | $37,674 | $7,964 | 21.1% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 14 | 14 | $19,950 | $7,909 | 39.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 192 | 216 | $21,600 | $7,355 | 34.1% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 18 | 24 | $10,800 | $7,329 | 67.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 136 | 195 | $14,625 | $7,053 | 48.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 43 | 55 | $20,130 | $6,110 | 30.4% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 53 | 54 | $32,400 | $6,004 | 18.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $12,152 | $5,659 | 46.6% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 30 | 31 | $18,600 | $5,513 | 29.6% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 39 | 39 | $20,241 | $4,790 | 23.7% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 28 | 30 | $14,970 | $2,965 | 19.8% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 14 | 14 | $14,784 | $2,617 | 17.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 55 | 262 | $10,742 | $2,457 | 22.9% |
| 12041 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.5 cm or less | Office | 2023 | 17 | 17 | $7,633 | $2,195 | 28.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $5,250 | $1,965 | 37.4% |
About Dr. Joshua Mandrell, M.D
Dr. Joshua Mandrell, M.D is a Dermatology healthcare provider based in Ruston, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770781650.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Mandrell, M.D has received a total of $6,791 in payments from pharmaceutical and medical device companies, with $1,182 received in 2024. These payments were reported across 372 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($6,119).
As a Medicare-enrolled provider, Mandrell has provided services to 17,152 Medicare beneficiaries, totaling 29,078 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Ruston, LA
- Active Since 07/03/2007
- Last Updated 01/21/2026
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1770781650
Products in Payments
- TREMFYA (Drug) $1,015
- DUPIXENT (Biological) $837.98
- RINVOQ (Biological) $627.39
- TALTZ (Drug) $527.16
- EUCRISA (Drug) $517.51
- SKYRIZI (Biological) $513.34
- Humira (Biological) $285.45
- OPZELURA (Drug) $265.99
- ADBRY (Biological) $241.77
- Tremfya (Drug) $202.75
- REMICADE (Biological) $193.14
- COSENTYX (Biological) $169.44
- COSENTYX (Drug) $135.35
- HUMIRA (Biological) $125.00
- STELARA (Biological) $98.70
- DUPIXENT DUPILUMAB INJECTION (Biological) $88.88
- Cimzia (Drug) $77.76
- Otezla (Drug) $74.63
- ILUMYA (Biological) $74.41
- Sotyktu (Drug) $69.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.